Shannon S Zhang (Shannon Zhang)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Small Cell Lung Cancer

Top Venues

Lung Cancer (Auckland, N.Z.)

Case reports in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Shannon S Zhang, Alexandria T M Lee, Misako Nagasaka
CodeBreak 200: Sotorasib Has Not Broken the KRAS G12C Enigma Code. Lung Cancer (Auckland, N.Z.) 14 (2023)
Shannon S Zhang, Alexandria T M Lee, Misako Nagasaka
CodeBreak 200: Sotorasib Has Not Broken the KRAS G12C Enigma Code. Lung Cancer (Auckland, N.Z.) 14 (2023)
Danielle Brazel, Shannon S Zhang, Misako Nagasaka
Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation. Lung Cancer (Auckland, N.Z.) 13 (2022)
Shannon S Zhang, Sai-Hong Ignatius Ou
Spotlight on Furmonertinib (Alflutinib, AST2818). The Swiss Army Knife (del19, L858R, T790M, Exon 20 Insertions, "uncommon-G719X, S768I, L861Q") Among the Third-Generation EGFR TKIs? Lung Cancer (Auckland, N.Z.) 13 (2022)
Shannon S Zhang, Sai-Hong Ignatius Ou
Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib. Lung Cancer (Auckland, N.Z.) 13 (2022)
Shannon S Zhang, Misako Nagasaka
Spotlight on Sotorasib (AMG 510) for KRAS G12C Positive Non-Small Cell Lung Cancer. Lung Cancer (Auckland, N.Z.) 12 (2021)
Shannon S Zhang, Casey Charlton, Akshay Amaraneni, Keri R Maher
A Case of Myeloid Sarcoma following Allogeneic HSCT Presenting as Localized Hip Pain. Case reports in hematology 2019 (2019)